GlassScriptPhysician profile
Hennessey Tseng
NPI 1003811746
$18,708.83
in general payments reported to CMS, 2019-2025
54 companies · $3,392 in 2025
The $3,392 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,704 · 2020: $1,559 · 2021: $1,722 · 2022: $3,567 · 2023: $3,442 · 2024: $2,323 · 2025: $3,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,105 · Education: $52.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,105.04 |
| Education | $52.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,814.95 | 2019-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Amgen INC. | $1,215.23 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,145.61 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $1,038.77 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $1,024.65 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $894.84 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $891.75 | 2019-2024 | Xarelto |
| Abbott Laboratories | $817.75 | 2019-2025 | Gallant, Assurity, Amplatzer Amulet |
| Aop Health US, LLC | $812.06 | 2025 | Rapiblyk |
| Astrazeneca Pharmaceuticals LP | $787.16 | 2021-2025 | Wainua, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $776.76 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $699.85 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $644.45 | 2022-2025 | Verquvo, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $520.06 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $453.12 | 2019-2024 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $441.61 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Novo Nordisk INC | $393.47 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $383.11 | 2019-2025 | |
| Esperion Therapeutics, INC. | $282.05 | 2023-2025 | Nexletol |
| Actelion Pharmaceuticals US, INC. | $254.13 | 2022-2025 | Opsumit, Uptravi |
| Heartflow, INC. | $242.86 | 2021-2025 | Ffrct |
| Alnylam Pharmaceuticals INC. | $189.88 | 2023-2025 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $183.13 | 2019-2025 | Evkeeza |
| Boston Scientific Corporation | $176.39 | 2019-2025 | Bodyguardian, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Lexicon Pharmaceuticals, INC. | $140.89 | 2023-2024 | Inpefa |
| Cvrx, INC. | $130.77 | 2025 | Barostim Neo System |
| Bridgebio Pharma, INC. | $117.22 | 2025 | Attruby |
| Akcea Therapeutics, INC. | $116.94 | 2019-2020 | |
| Edwards Lifesciences Corporation | $111.15 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals, LTD. | $108.67 | 2022-2023 | Arcalyst |
| Daiichi Sankyo INC. | $78.35 | 2023 | Injectafer |
| Glaxosmithkline, LLC. | $76.61 | 2022-2025 | Shingrix |
| Lilly USA, LLC | $72.03 | 2019-2025 | Mounjaro, Zepbound |
| Kiniksa Pharmaceuticals International, Plc | $63.83 | 2024 | Arcalyst |
| Lundbeck LLC | $57.54 | 2019 | |
| Abiomed | $46.61 | 2024 | Impella |
| Biohaven Pharmaceutical Holding Company LTD. | $46.23 | 2022 | |
| Medtronic, INC. | $46.03 | 2022 | |
| Inspire Medical Systems, INC. | $43.58 | 2024 | Inspire |
| Medtronic Vascular, INC. | $41.84 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $38.04 | 2019 | |
| Scpharmaceuticals INC. | $36.10 | 2025 | |
| Braemar Manufacturing, LLC | $34.04 | 2019 | |
| Kestra Medical Technology Services, INC. | $29.84 | 2022-2024 | Assure Wcd |
| Elutia, INC. | $27.99 | 2021 | |
| Cleerly, INC. | $25.10 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Ultragenyx Pharmaceutical INC. | $21.14 | 2025 | Dojolvi |
| Cordis US Corp. | $20.39 | 2025 | Mynx Control Venous |
| Microvention, INC. | $19.35 | 2022 | |
| Agepha Pharma Fz LLC | $18.44 | 2025 | Lodoco |
| Biogen, INC. | $16.43 | 2024 | Skyclarys |
| Avion Pharmaceuticals | $14.77 | 2019 | |
| Irhythm Technologies, INC. | $12.87 | 2019 | |
| Circassia INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hennessey Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.